Formononetin Induces Ferroptosis in Activated Hepatic Stellate Cells to Attenuate Liver Fibrosis by Targeting NADPH Oxidase 4.
Autor: | Liu MX; College of Pharmacy, Nantong University, Nantong, People's Republic of China., Gu YY; College of Pharmacy, Nantong University, Nantong, People's Republic of China., Nie WY; College of Pharmacy, Nantong University, Nantong, People's Republic of China., Zhu XM; College of Pharmacy, Nantong University, Nantong, People's Republic of China., Qi MJ; College of Pharmacy, Nantong University, Nantong, People's Republic of China., Zhao RM; College of Pharmacy, Nantong University, Nantong, People's Republic of China., Zhu WZ; College of Pharmacy, Nantong University, Nantong, People's Republic of China., Zhang XL; College of Pharmacy, Nantong University, Nantong, People's Republic of China. |
---|---|
Jazyk: | angličtina |
Zdroj: | Phytotherapy research : PTR [Phytother Res] 2024 Dec; Vol. 38 (12), pp. 5988-6003. Date of Electronic Publication: 2024 Oct 30. |
DOI: | 10.1002/ptr.8338 |
Abstrakt: | Ferroptosis is a newly discovered type of cell death that exerts a crucial role in hepatic fibrosis. Formononetin (FMN), a natural isoflavone compound mainly isolated from Spatholobus suberectus Dunn, shows multiple biological activities, including antioxidant, anti-inflammatory, and hepatoprotection. This research aims to explore the regulatory mechanism of FMN in liver fibrosis and the relationship between NADPH oxidase 4 (NOX4) and ferroptosis. The effects of FMN on HSC ferroptosis were evaluated in rat model of CCl (© 2024 John Wiley & Sons Ltd.) |
Databáze: | MEDLINE |
Externí odkaz: |